Freedom Inguinal Hernia Repair System Study

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

Clinical Trial Summary

The primary objective of this study is to evaluate patient quality-of-life (QOL) after inguinal hernia repair. "Carolinas Comfort Scale" (CCS) assessments will be held at regular intervals.

The secondary objective of the study is to follow short-term and long-term study-related complications/adverse events.

NCT number	NCT01984996
Study type	Interventional
Source	Insightra Medical, Inc.
Contact
Status	Terminated
Phase	N/A
Start date	December 2013

Status	Clinical Trial	Phase
Recruiting	`NCT03488342` - Rives Technique Versus Lichtenstein Repair for Primary Inguinal Hernia	N/A
Terminated	`NCT01596049` - The Efficacy of a Self-fixating Mesh in Unilateral Open Inguinal Hernia Repair	N/A
Recruiting	`NCT06406959` - The Effect of Preemptive Regional Anesthesia (TAP-block) on Acute and Chronic Pain After Transabdominal Preperitoneal Inguinal Hernia Repair (TAPP)	N/A

Freedom Inguinal Hernia Repair System Study

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms